Cargando…
Hyperoncotic Albumin Solution in Continuous Renal Replacement Therapy Patients
AIM: The aim of this study was to investigate the association of hyperoncotic (20%) human albumin solution (HAS) with outcomes among critically ill patients receiving continuous renal replacement therapy (RRT). METHODS: Analysis of the Randomized Evaluation of Normal versus Augmented Level (RENAL) R...
Autores principales: | O'Brien, Zachary, Finnis, Mark, Gallagher, Martin, Bellomo, Rinaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393816/ https://www.ncbi.nlm.nih.gov/pubmed/34515056 http://dx.doi.org/10.1159/000517957 |
Ejemplares similares
-
Continuous Renal Replacement Therapy in Acute Brain Injury
por: Cruz-Llanos, Luis, et al.
Publicado: (2022) -
Criteria for Continuous Kidney Replacement Therapy Cessation in ICU Patients
por: Volbeda, Meint, et al.
Publicado: (2023) -
Development and External Validation of a Model for Predicting Sufficient Filter Lifespan in Anticoagulation-Free Continuous Renal Replacement Therapy Patients
por: Zhang, Wei, et al.
Publicado: (2022) -
Experiences of Renal Replacement Therapy Delivery in Swedish Intensive Care Units during the COVID-19 Pandemic
por: Hertzberg, Daniel, et al.
Publicado: (2022) -
HMGB1 Is a Prognostic Factor for Mortality in Acute Kidney Injury Requiring Renal Replacement Therapy
por: Matsuura, Ryo, et al.
Publicado: (2023)